Filgotinib for Treating Moderately to Severely Active Ulcerative Colitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Saved in:
| Title: | Filgotinib for Treating Moderately to Severely Active Ulcerative Colitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. |
|---|---|
| Authors: | van Asselt, Antoinette D. I.1,2 (AUTHOR) a.d.i.van.asselt@umcg.nl, Armstrong, Nigel3 (AUTHOR), Kimman, Merel4,5 (AUTHOR), Peeters, Andrea4 (AUTHOR), McDermott, Kevin3 (AUTHOR), Stirk, Lisa3 (AUTHOR), Ahmadu, Charlotte3 (AUTHOR), Govers, Tim M.6 (AUTHOR), Hoentjen, Frank7,8 (AUTHOR), Joore, Manuela A.4,5 (AUTHOR), Grimm, Sabine E.4 (AUTHOR) |
| Source: | PharmacoEconomics. Mar2023, Vol. 41 Issue 3, p239-251. 13p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 161884398 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Filgotinib for Treating Moderately to Severely Active Ulcerative Colitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22van+Asselt%2C+Antoinette+D%2E+I%2E%22">van Asselt, Antoinette D. I.</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> a.d.i.van.asselt@umcg.nl</i><br /><searchLink fieldCode="AR" term="%22Armstrong%2C+Nigel%22">Armstrong, Nigel</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kimman%2C+Merel%22">Kimman, Merel</searchLink><relatesTo>4,5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Peeters%2C+Andrea%22">Peeters, Andrea</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22McDermott%2C+Kevin%22">McDermott, Kevin</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Stirk%2C+Lisa%22">Stirk, Lisa</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ahmadu%2C+Charlotte%22">Ahmadu, Charlotte</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Govers%2C+Tim+M%2E%22">Govers, Tim M.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hoentjen%2C+Frank%22">Hoentjen, Frank</searchLink><relatesTo>7,8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Joore%2C+Manuela+A%2E%22">Joore, Manuela A.</searchLink><relatesTo>4,5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Grimm%2C+Sabine+E%2E%22">Grimm, Sabine E.</searchLink><relatesTo>4</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22PharmacoEconomics%22">PharmacoEconomics</searchLink>. Mar2023, Vol. 41 Issue 3, p239-251. 13p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=161884398 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s40273-023-01244-z Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 13 StartPage: 239 Titles: – TitleFull: Filgotinib for Treating Moderately to Severely Active Ulcerative Colitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: van Asselt, Antoinette D. I. – PersonEntity: Name: NameFull: Armstrong, Nigel – PersonEntity: Name: NameFull: Kimman, Merel – PersonEntity: Name: NameFull: Peeters, Andrea – PersonEntity: Name: NameFull: McDermott, Kevin – PersonEntity: Name: NameFull: Stirk, Lisa – PersonEntity: Name: NameFull: Ahmadu, Charlotte – PersonEntity: Name: NameFull: Govers, Tim M. – PersonEntity: Name: NameFull: Hoentjen, Frank – PersonEntity: Name: NameFull: Joore, Manuela A. – PersonEntity: Name: NameFull: Grimm, Sabine E. IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: Mar2023 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 11707690 Numbering: – Type: volume Value: 41 – Type: issue Value: 3 Titles: – TitleFull: PharmacoEconomics Type: main |
| ResultId | 1 |